Click here to BLOCK YOUR CONTENT SPACE IN OUR NEXT ISSUES |
| |
 |
Insights |
|
|
Converting Injectable Therapies to Combination Drug-Device Products
The global biopharma market has recently experienced a remarkable period of evolution and expansion. In that time, parenteral medications have become one of the industry’s most important innovation and growth drivers.
|
|
 |
| |
| |
| |
|
|
Regulators Agree To Work Together On The Unification of RWE
Global regulators have committed to collaborating together to integrate real-world data and real-world evidence into the process of making regulatory decisions.
|
|
| |
 |
Latest News |
|
|
Indian Pharma Exports Rose By 8% In The Q1 To $6.26 Billion
With 146% rise in exports from April-June 2022 compared to same period in 2013, Made in India pharmaceutical product exports continue to climb to new heights.
|
|
 |
|
|
| |
| |
|
|
Big Data Steering Group To Optimize Data Quality, Visibility
Among other things, Group intends to complete a data quality methodology by the end of 2022 and issue a public directory of European real-world data by 2025.
|
|
|
| |
|
85mn Pandemic Flu Vaccines To Be Supplied By GSK To Europe
With agreement in place, at the very minimum 200 million doses of the pandemic influenza vaccine might be made accessible to the governments worldwide by GSK.
|
|
 |
|
|
| |
| |
|
|
GenKOre- Korea Creating Base-Editing Tech For Genetic Issues
To attract a large number of human resources for development of hypercompact ABEs-based gene therapy, GenKOre recently expanded its research facility in Seoul.
|
|
| |
|
COVID-19 Updates |
|
|
September May Bring Updated COVID-19 Booster Shots To Market
Depending on approval, boosters from Moderna and Pfizer that have been improved to tackle Omicron coronavirus subvariants may be available in the early fall.
|
|
 |
|
|
| |
| |
|
|
For Those With Chronic Signs, NHS Has Rolled Long COVID Plan
The long COVID may be unpleasant for the individuals who have it, however they must realize that they are not alone and the NHS is available for them always.
|
|
|
| |
|
Pfizer Is Committed To Paxlovid Role In Stalling COVID-19
Pfizer is pretty pleased with the progress that has been made with Paxlovid in the United States, where there are over 41,000 locations that have its supply.
|
|
 |
|
|
